1. South Korea Stocks

  2. •

    Healthcare

  3. •

    Medical - Pharmaceuticals
KUKJE PHARMA Co., Ltd.

KUKJE PHARMA Co., Ltd.

002720.KS
KUKJE PHARMA Co., Ltd.KR flagKorea Exchange
3,365.00
KRW
-15.00
- -
71.20BMarket Cap

Total Valuation

KUKJE PHARMA Co., Ltd. carries a market capitalization of 71.20B, placing it among publicly traded companies globally. Its enterprise value stands at 120.10B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap71.20B
Enterprise Value120.10B

Share Statistics

KUKJE PHARMA Co., Ltd. currently has 20.36M shares outstanding.

Shares Outstanding20.36M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

KUKJE PHARMA Co., Ltd. trades at a trailing price-to-earnings ratio of 16.45. The price-to-sales ratio is 0.55, and the price-to-book ratio stands at 2.96.

PE Ratio16.45
PS Ratio0.55
PB Ratio2.96
P/TBV Ratio1.01
P/FCF Ratio14.44
P/OCF Ratio33.67

Enterprise Valuation

On an enterprise value basis, KUKJE PHARMA Co., Ltd. trades at an EV/EBITDA multiple of 20.53 and an EV/FCF ratio of 15.87. The EV/Sales ratio of 0.67 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 20.53 provides insight into valuation relative to core operating earnings.

EV / Sales0.67
EV / EBITDA20.53
EV / EBIT20.53
EV / FCF15.87

Financial Position

KUKJE PHARMA Co., Ltd. maintains a current ratio of 1.09, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 31.39, indicating elevated leverage, while an interest coverage ratio of 6.87 demonstrates adequate ability to service its debt obligations.

Current Ratio1.09
Quick Ratio0.16
Debt / Equity31.39
Debt / EBITDA5.29
Interest Coverage6.87

Financial Efficiency

KUKJE PHARMA Co., Ltd. posts a return on equity of 19.63 and a return on invested capital of 4.17.

Return on Equity (ROE)19.63
Return on Assets (ROA)3.49
Return on Invested Capital (ROIC)4.17
Return on Capital Employed (ROCE)11.10
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover3.73

Taxes

Over the trailing twelve months, KUKJE PHARMA Co., Ltd. has paid 839.88M in income taxes, reflecting an effective tax rate of 12.29.

Income Tax839.88M
Effective Tax Rate12.29

Stock Price Statistics

KUKJE PHARMA Co., Ltd.'s stock has declined approximately -31.67513% over the past 52 weeks. The 50-day moving average sits at 3,901.30, while the 200-day moving average is 4,363.63.

Beta (5Y)N/A
52-Week Price Change-31.67513%
50-Day Moving Average3,901.30
200-Day Moving Average4,363.63
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, KUKJE PHARMA Co., Ltd. generated 177.97B in revenue and converted that into 5.99B in net income, yielding earnings per share of 290.90. EBITDA reached 5.85B, while operating income came in at 5.85B.

Revenue177.97B
Gross Profit95.08B
Operating Income5.85B
Pretax Income6.83B
Net Income5.99B
EBITDA5.85B
EBIT5.85B
Earnings Per Share (EPS)290.90

Balance Sheet

KUKJE PHARMA Co., Ltd. holds 9.38B in cash and equivalents against 30.92B in total debt, resulting in a net debt position of 20.92B. Total book value stands at 33.28B, with working capital of 5.51B providing operational flexibility.

Cash & Cash Equivalents9.38B
Total Debt30.92B
Net Debt20.92B
Equity (Book Value)33.28B
Book Value Per Share1,615.66
Working Capital5.51B

Cash Flow

KUKJE PHARMA Co., Ltd. produced 2.93B in operating cash flow over the past twelve months. After subtracting -3.90B in capital expenditures, free cash flow totaled -969.87M - equivalent to -47.09 per share.

Operating Cash Flow2.93B
Capital Expenditures-3.90B
Free Cash Flow-969.87M
FCF Per Share-47.09

Margins

KUKJE PHARMA Co., Ltd. operates with a gross margin of 53.42, reflecting its pricing power and cost economics. The operating margin of 3.29 and net profit margin of 3.37 provide insight into operational efficiency.

Gross Margin53.42
Operating Margin3.29
Pretax Margin3.84
Profit Margin3.37
EBITDA Margin3.29

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield-0.34
FCF Yield6.92

Stock Splits

KUKJE PHARMA Co., Ltd.'s most recent stock split took place on March 17, 2023 with a 20:21 split ratio.

Last Split Date3/17/2023
Split Ratio20:21

Scores

KUKJE PHARMA Co., Ltd. posts an Altman Z-Score of 1.98, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score1.98